AdnaGen AG is a biotechnology company that develops molecular genetic diagnostic testing systems for the medical and clinical research laboratories. The company offers AdnaTest kits including reagents for immunomagnetic selection, mRNA isolation, and multiplex RT-PCR for tumor diagnostics. In addition, it focuses on genetic pre-disposition, pharmoco genetics, and non-invasive prenatal diagnostic systems for early detection, prevention, and monitoring of human diseases. The company was founded in 1999 and is headquartered in Langenhagen, Germany. As of February 23, 2006, AdnaGen AG is a subsidiary of OncoVista, Inc.
Recent Milestones
-
Posted 9/16/09 at 6:21am
-
Posted 9/16/09 at 6:05am
-
Posted 9/16/09 at 6:05am
Videos
Screenshots
Sources
-
Cap Funding Report [edit]
